ASX closes 0.62% lower: Australia’s manufacturing activity continues to slow

In November, Australian manufacturing activity continued to decline, with the flash composite output index dropping to 46.4, marking its lowest level in eight years, excluding pandemic lockdowns. However, experts believe that this indicates a soft landing for the economy rather than a hard one, aligning with the Reserve Bank of Australia's expectations.

Read More

Chariot’s off to the races

Chariot Corporation (ASX:CC9) witnessed a remarkable 35% increase in its share price yesterday, closing at 70 cents with $700,000 in stock trading volume,. And the positive results have been continuing today, currently trading above 6% higher at 74.5c (2:00pm AEDT). While no new developments were reported today, the recent announcement of the arrival of a drill rig at CC9's flagship Black Mountain Project in Wyoming, USA, has been driving investor interest over the past two weeks.

Read More

Linius Technologies breaks into US college sports with Peach Belt Conference deal

Linius Technologies (ASX:LNU), a pioneer in cloud-based video solutions, is set to make a significant impact on the US college sports market with its latest venture. Linius has announced a groundbreaking agreement to provide its sports solution, Whizzard, to the Peach Belt Conference (PBC), marking its entry into the lucrative US collegiate sports market.

Read More

Chimeric Therapeutics shows promise in ovarian and pancreatic cancers

Chimeric Therapeutics (ASX:CHM), an Australian company specialising in cell therapy, has reported significant in vitro findings for its chlorotoxin (CLTX) chimeric antigen receptor (CAR) NK cell therapy, CHM 1301. These preclinical results highlight the therapy's notable efficacy against ovarian and pancreatic cancers, suggesting potential advancements in cancer treatment.

Read More